HomeAVBP • NASDAQ
add
Arrivent Biopharma Inc
Previous close
$19.24
Day range
$18.97 - $19.55
Year range
$15.47 - $36.20
Market cap
662.36M USD
Avg Volume
207.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 26.77M | 29.50% |
Net income | -64.39M | -269.68% |
Net profit margin | — | — |
Earnings per share | -1.90 | -171.43% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 176.08M | -44.52% |
Total assets | 215.50M | -34.27% |
Total liabilities | 12.95M | 28.06% |
Total equity | 202.54M | — |
Shares outstanding | 34.21M | — |
Price to book | 3.23 | — |
Return on assets | -27.29% | — |
Return on capital | -29.07% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -64.39M | -269.68% |
Cash from operations | -68.01M | -265.08% |
Cash from investing | 36.82M | — |
Cash from financing | 6.76M | -96.36% |
Net change in cash | -24.43M | -114.63% |
Free cash flow | -20.35M | -40.75% |
About
Founded
2021
Headquarters
Website
Employees
52
